Dr. Dario Brunetti is the group leader of the Unit of Medical Genetics and Neurogenetics at the Fondazione IRCCS Istituto Neurologico Carlo Besta. He has also been a research scientist at the Department of Medical Biotechnology and Translational Medicine, University of Milan, since 2018. He received his Master’s degree at the University of Bologna in 2004 and completed his PhD studies in biotechnology at the University of Milan in 2010. He subsequently did a first postdoctoral training (2010–2013) in Molecular Neurogenetics at the Carlo Besta Neurological Institute in Milan and a second postdoctoral training (2013–2018) in Mitochondrial Medicine at the University of Cambridge (UK). He does research in the field of mitochondrial dysfunction related to neurogenetic diseases and aging. His current research interests include the pharmacological stimulation of mitochondrial biogenesis and mitochondrial quality control as therapeutic targets. His research activity is also focused on the development of in utero fetal gene therapy for mitochondrial diseases.